| Trial registration number
|
IRCT20201210049672N1 |
Full text link
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/62519
|
First author
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Teamur Aghamolaei
|
Contact
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
teaghamolaei@gmail.com
|
Registration date
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-03-17
|
Recruitment status
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Definitive COVID-19 diagnosis based on PCR results
Admission to the intensive care unit
|
Exclusion criteria
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Hypersensitivity to heparin and N-acetyl cysteine
Coagulopathies
|
Number of arms
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
3
|
Funding
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Vice-Chancellery for Research Hormozgan University of Medical Sciences
|
Inclusion age min
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
0
|
Inclusion age max
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Severe disease at enrollment
|
Severity scale
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
6: Severe disease at enrollment
|
Total sample size
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
25
|
primary outcome
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Intensive care unit length of stay
|
Notes
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : June 12, 2022, 5:11 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2532, "treatment_name": "N-acetylcysteine+nebulised unfractionated heparin (ufh)", "treatment_type": "Respiratory agents+coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 873, "treatment_name": "Nebulised unfractionated heparin (ufh)", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|